ID: ALA377741

Max Phase: Preclinical

Molecular Formula: C31H31Br2IN6O5

Molecular Weight: 854.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [N-]=[N+]=Nc1ccc(I)cc1C(=O)NCCCC[C@H]1CC(=O)NCCc2cc(Br)c(O)c(c2)Oc2ccc(cc2Br)CCC(=O)N1

Standard InChI:  InChI=1S/C31H31Br2IN6O5/c32-23-13-18-4-8-26(23)45-27-15-19(14-24(33)30(27)43)10-12-36-29(42)17-21(38-28(41)9-5-18)3-1-2-11-37-31(44)22-16-20(34)6-7-25(22)39-40-35/h4,6-8,13-16,21,43H,1-3,5,9-12,17H2,(H,36,42)(H,37,44)(H,38,41)/t21-/m0/s1

Standard InChI Key:  HTOXGXWFSVQOMS-NRFANRHFSA-N

Associated Targets(Human)

RyR1/FKBP12 34 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 854.34Molecular Weight (Monoisotopic): 851.9767AlogP: 7.34#Rotatable Bonds: 7
Polar Surface Area: 165.52Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: -10.85CX Basic pKa: CX LogP: 6.69CX LogD: 6.10
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.06Np Likeness Score: 0.56

References

1. Masuno MN, Pessah IN, Olmstead MM, Molinski TF..  (2006)  Simplified cyclic analogues of bastadin-5. Structure-activity relationships for modulation of the RyR1/FKBP12 Ca2+ channel complex.,  49  (15): [PMID:16854055] [10.1021/jm050708u]

Source